Education
About Us
Working with TipRanks
Follow Us
The United Laboratories International Holdings Limited (ULIHF)
OTHER OTC:ULIHF
RESEARCH TOOLSreports
Total Valuation
The United Laboratories International Holdings has a market cap or net worth of $3.07B. The enterprise value is ―.
Market Cap$3.07B
Enterprise Value―
Share Statistics
The United Laboratories International Holdings has 1,817,026,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,817,026,500
Owned by Insiders―
Owned by Institutions0.09%
Financial Efficiency
The United Laboratories International Holdings’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 14.07%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)14.07%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee809.35K
Profits Per Employee193.46K
Employee Count17,000
Asset Turnover0.53
Inventory Turnover3.15
Valuation Ratios
The current PE Ratio of The United Laboratories International Holdings is 7.93. The United Laboratories International Holdings’s PEG ratio is -0.95.
PE Ratio7.93
PS Ratio0.00
PB Ratio1.53
Price to Fair Value1.47
Price to FCF20.63
Price to Operating Cash Flow11.92
PEG Ratio-0.95
Income Statement
In the last 12 months, The United Laboratories International Holdings had revenue of 13.76B and earned 2.66B in profits. Earnings per share was 1.46.
Revenue13.76B
Gross Profit6.08B
Operating Income3.12B
Pretax Income3.29B
Net Income2.66B
EBITDA3.35B
Earnings Per Share (EPS)1.46
Cash Flow
In the last 12 months, operating cash flow was 1.85B and capital expenditures -779.15M, giving a free cash flow of 1.07B billion.
Operating Cash Flow1.85B
Free Cash Flow1.07B
Free Cash Flow per Share0.59
Dividends & Yields
The United Laboratories International Holdings pays an annual dividend of $0.039, resulting in a dividend yield of 5.52%
Dividend Per Share$0.039
Dividend Yield5.52%
Payout Ratio19.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.37
52-Week Price Change8.40%
50-Day Moving Average1.62
200-Day Moving Average1.43
Relative Strength Index (RSI)32.46
Average Volume (3m)34.00
Important Dates
The United Laboratories International Holdings upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 25, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateJul 08, 2025
Financial Position
The United Laboratories International Holdings as a current ratio of 1.83, with Debt / Equity ratio of 21.93%
Current Ratio1.83
Quick Ratio1.55
Debt to Market Cap0.15
Net Debt to EBITDA-0.95
Interest Coverage Ratio0.00
Taxes
In the past 12 months, The United Laboratories International Holdings has paid 631.08M in taxes.
Income Tax631.08M
Effective Tax Rate0.19
Enterprise Valuation
The United Laboratories International Holdings EV to EBITDA ratio is 5.35, with an EV/FCF ratio of 0.00.
EV to Sales1.30
EV to EBITDA5.35
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
The United Laboratories International Holdings has $6.33B in cash and marketable securities with ¥3.16B in debt, giving a net cash position of -$3.17B billion.
Cash & Marketable Securities$6.33B
Total Debt¥3.16B
Net Cash-$3.17B
Net Cash Per Share-$1.75
Tangible Book Value Per Share$7.83
Margins
Gross margin is 44.21%, with operating margin of 22.65%, and net profit margin of 19.33%.
Gross Margin44.21%
Operating Margin22.65%
Pretax Margin23.90%
Net Profit Margin19.33%
EBITDA Margin24.36%
EBIT Margin20.45%
Analyst Forecast
The average price target for The United Laboratories International Holdings is $2.07, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.07
Price Target Upside45.77% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―